Current Position: Chief Scientific Officer of Leadiant Biosciences S.p.A.
After graduating as Medical Doctor in 1984 at the University of Milan, and following a Post Doctorate at Bowman Gray School of Medicine (USA), he joined the pharma industry in 1988.
He joined sigma-tau in 1998 as Director of Scientific Office and Strategic Alliances within the Corporate R&D organization. He has also been Chief Executive Officer of Leadiant Biosciences SA (formerly sigma-tau Research Switzerland) from 2007 to 2017. He worked in several therapeutic (and diagnostic) areas, but mostly in high unmet medical need specialty areas as cancer, immune-oncology and rare diseases.